[Progress in the treatment of diabetic patients with ischemic cardiopathy]

Area of Science:

• Cardiology
• Diabetology
• Vascular Biology

Context:

• Diabetes mellitus is a major risk factor for ischemic cardiopathy, contributing to high cardiovascular disease mortality.
• Diabetic patients undergoing treatment for ischemic cardiopathy face higher rates of restenosis and mortality compared to non-diabetic individuals.
• Despite advancements like glycoprotein IIb/IIIa inhibitors and coronary stents, restenosis remains a significant challenge in diabetic patients.

Purpose:

• To review current treatment strategies for ischemic cardiopathy in diabetic patients.
• To highlight the persistent challenges of restenosis and mortality in this population.
• To explore potential novel therapeutic approaches for managing coronary artery disease in diabetes.

Summary:

• Coronary artery bypass grafting is often the preferred revascularization strategy for diabetic patients with complex multi-vessel coronary artery disease.
• Intracoronary radiation has demonstrated efficacy in reducing restenosis and repeat revascularizations in diabetic patients with intra-stent restenosis.
• Pharmacological and molecularly coated stents show promise in suppressing intimal hyperplasia and preventing restenosis in diabetic patients.

Impact:

• Improved understanding of treatment efficacy and limitations in diabetic ischemic cardiopathy.
• Identification of promising avenues for future research and therapeutic development.
• Potential for enhanced long-term outcomes and reduced mortality in diabetic patients with coronary artery disease.